Medicare Negotiation Does Not Violate Due Process, Appeals Court Rules, Other Suits At Risk

Decision in AstraZeneca’s lawsuit against the Health and Human Services Department is a precedent-setting victory for the government and a blow to manufacturer efforts to block the price negotiation program.